Volume 13, Number 10—October 2007
Global Poverty and Human Development
Influenza A and B Infection in Children in Urban Slum, Bangladesh
To the Editor: Influenza A and B viruses are associated with seasonal epidemics (1). Influenza is increasingly recognized as a cause of severe respiratory disease among healthy children in industrialized countries (2–4). However, little information is available from developing countries (5).
We assessed the contribution of influenza and other respiratory viruses to febrile respiratory illness among children enrolled at the ICDDR,B Kamalapur surveillance and intervention site (6) in an urban slum in Dhaka, Bangladesh. This study was reviewed and approved by the Research Review and Ethical Review Committees of ICDDR,B and the Institutional Review Board of the Centers for Disease Control and Prevention (CDC) (Atlanta, GA, USA).
Surveillance in Kamalapur has been described (6,7). Briefly, the site is divided into 7 geographic strata and subdivided into geographic clusters of 50–100 households. Eighty-six clusters were randomly selected and 5,000 households within those clusters were enrolled after written consent was obtained.
Prospective fever surveillance methodology has been described (7). To evaluate viral causes of febrile respiratory illness, paired (acute- and convalescent-phase) serum specimens were retrospectively selected from the surveillance period of December 6, 2000 to December 5, 2001, from patients with documented fever >38.5°C, a cough for >1 day but <4 days, and age <13 years, and who were negative for antibodies to dengue by immunoglobulin M (IgM) antibody-capture ELISA.
Sera were tested by hemagglutination inhibition (HI) for influenza A (H1N1 and H3N2) virus and B virus, and by ELISA for respiratory syncytial virus, parainfluenza virus types 1, 2, and 3, adenovirus, and human metapneumovirus at CDC by using standard methods (8). Acute infection was defined as IgM in serum sample or a >4-fold increase in IgG titer between acute- and convalescent-phase serum samples for noninfluenza viruses or a >4-fold increase in HI titer for influenza viruses.
Statistical analysis was performed by using Stata Statistical Software Release 8.2, 2003 (Stata Corporation, College Station, TX, USA). Continuous variables were compared by using analysis of variance. Univariate categorical analysis was conducted by using 2 × 2 tables to obtain odds ratios (ORs) and 95% confidence intervals (CIs). Multivariate analysis was conducted by using stepwise forward logistic regression and all covariates significant with a 5% precision in univariate analysis. We adjusted the model for clustering (multiple observations per patient) and tested for goodness of fit.
Of 889 patients who came to the ICDDR, B Kamalpur field clinic with fever during the surveillance period, 198 (22%) met inclusion criteria for retrospective sampling. Of these, 128 had adequate paired serum specimens for influenza testing. Only 107 (83.6%) pairs had sufficient serum remaining for testing for other viruses.
Of 128 children, 21 (16%) had acute influenza infections; 2 of these children had both influenza A and B. Overall, 10 influenza A (8 H1N1 and 2 H3N2) and 13 influenza B infections were detected (Table). Other respiratory virus infections were detected in 33 children and accounted for 35 noninfluenza virus infections (Table). One child was coinfected with both influenza A (H3N2) virus and HMPV. Seven (70%) of 10 influenza A cases occurred during April–June (pre-monsoon period), and 10 (77%) influenza B cases occurred during July–September (monsoon period).
Data for 107 serum pairs tested for both influenza and other viruses indicated that influenza-infected children were older than children without influenza (OR 3.1, 95% CI 1.1–9.3). Multivariate analysis indicated that only reported body pain was more common in influenza patients than in others (OR 3.3, 95% CI 1.5–7.1). Three influenza-infected children had clinical pneumonia (tachypnea defined by the World Health Organization) with crepitations.
We confirmed that influenza A and B were common causes of febrile illness among children in Dhaka. Because these infections were identified in 1 of 6 dengue-negative febrile children tested for influenza, these infections may play a substantial role in respiratory diseases in these children. Our study confirms findings of a previous hospital study (9) but provides additional information for nonhospitalized febrile children. Acute infections coincided with the warm pre-monsoon and monsoon periods.
Our study had several limitations. First, the surveillance system was not originally designed to identify influenza and relied on fever for specimen collection. Our retrospective selection criteria reflected the classic initial manifestations of influenza (1,4), and thus could have missed nonfebrile cases. Second, the study was not designed to reflect age distribution of children with respiratory infection, but rather those with fever and who had adequate amounts of available sera. This feature potentially biases toward older children. Third, data describe only 1 year, and patterns of illness may differ in other years. Fourth, acute infection was determined by serologic analysis. Previous studies in Bangladesh reported nutrition-related impaired immune responsiveness (10). Thus, some influenza-infected children who showed a nondetectable immune response may not have been included.
These findings indicate that influenza and other respiratory viruses contribute to pediatric febrile illness in urban Bangladesh. They also justify prospective surveillance to better define epidemiology and clinical findings associated with these viruses.
This study was supported by the International Center for Tropical Disease Research of the National Institutes of Health, a cooperative agreement from the US Agency for International Development (HRN-A-00-96-90005-00), and by core donors to ICDDR,B.
- Smith NM, Bresee JS, Shay DK, Uyeki TM, Cox NJ, Strikas RA. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006;55(RR-10):1–42.
- Heikkinen T, Silvennoinen H, Peltola V, Ziegler T, Vainionpaa R, Vuorinen T, Burden of influenza in children in the community. J Infect Dis. 2004;190:1369–73.
- Peltola V, Ziegler T, Ruuskanen O. Influenza A and B virus infections in children. Clin Infect Dis. 2003;36:299–305.
- Poehling KA, Edwards KM, Weinberg GA, Szilagyi P, Staat MA, Iwane MK, The underrecognized burden of influenza in young children. N Engl J Med. 2006;355:31–40.
- Stansfield SK. Acute respiratory infections in the developing world: strategies for prevention, treatment and control. Pediatr Infect Dis J. 1987;6:622–9.
- Brooks WA, Santosham M, Naheed A, Goswami D, Wahed MA, Diener-West M, Effect of weekly zinc supplements on incidence of pneumonia and diarrhoea in children younger than 2 years in an urban, low-income population in Bangladesh: randomised controlled trial. Lancet. 2005;366:999–1004.
- Brooks WA, Hossain A, Goswami D, Nahar K, Alam K, Ahmed N, Bacteremic typhoid fever in children in an urban slum, Bangladesh. Emerg Infect Dis. 2005;11:326–9.
- Falsey AR, Erdman D, Anderson LJ, Walsh EE. Human metapneumovirus infections in young and elderly adults. J Infect Dis. 2003;187:785–90.
- Huq F, Rahman M, Nahar N, Alam A, Haque M, Sack DA, Acute lower respiratory tract infection due to virus among hospitalized children in Dhaka, Bangladesh. Rev Infect Dis. 1990;12(Suppl 8):S982–7.
- Zaman K, Baqui AH, Yunus M, Sack RB, Chowdhury HR, Black RE. Malnutrition, cell-mediated immune deficiency and acute upper respiratory infections in rural Bangladeshi children. Acta Paediatr. 1997;86:923–7.
Suggested citation for this article: Brooks WA, Terebuh P, Bridges C, Klimov A, Goswami D, Sharmeen AT, et al. Influenza A and B infection in children in urban slum, Bangladesh [letter]. Emerg Infect Dis [serial on the Internet]. 2007 Oct [date cited]. Available from http://wwwnc.cdc.gov/eid/article/13/10/07-0368
- Page created: July 02, 2010
- Page last updated: July 02, 2010
- Page last reviewed: July 02, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)